SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their 
Investment in Affymax, Inc. of Class Action Lawsuit and the
Deadline of April 29, 2013 to Seek a Lead Plaintiff Position 
NEW YORK, NY -- (Marketwired) -- 04/05/13 --  Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
United States District Court for the Northern District of California
on behalf of investors who purchased Affymax, Inc. ("Affymax" or the
"Company") (NASDAQ: AFFY) stock between December 8, 2011 and February
22, 2013 (the "Class Period"). 
For more information, click here: http://zlk.9nl.com/affymax-affy/.  
The complaint alleges that during the Class Period, defendants failed
to disclose that 2% of patients administered the drug Omontys
experienced hypersensitivity reactions resulting in anaphylaxis, a
serious and life-threatening allergic reaction, a third of which
needed medical intervention, and that 0.02% of those administered the
drug experienced fatal anaphylaxis reactions. As a result, the
Complaint alleges that Affymax stock traded at artificially inflated
prices during the Class Period.  
On February 23, 2013, it was announced that the U.S. Food and Drug
Administration ("FDA") was requiring a total recall of the drug due
to reports of anaphylaxis. The FDA reported that "serious and fatal"
hypersensitivity reactions had been reported in some patients within
30 minutes of receiving their first doses of the drug by intravenous
injection. On this news, the price of Affymax stock declined by more
than 85%, closing at $2.42 per share, down $14.10 per share from the
prior night's close. 
If you suffered a loss in Affymax you have until April 29, 2013 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at (877)
363-5972, or visit http://zlk.9nl.com/affymax-affy/. 
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, and Washington D.C. The firm has extensive expertise in
prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and
shareholder lawsuits. Attorney advertising. Prior results do not
guarantee similar outcomes. 
CONTACT: 
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004 
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com 
 
 
Press spacebar to pause and continue. Press esc to stop.